about
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st CenturyModulation of oxidative stress and microinflammatory status by colloids in refractory dialytic hypotensionSchönlein-henoch purpura in children and adults: diagnosis, pathophysiology and management.Maximal standard dose of parenteral iron for hemodialysis patients: an MRI-based decision tree learning analysis.Cinacalcet to prevent parathyrotoxic crises in hypercalcaemic patients awaiting parathyroidectomy.Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study.Targets for adapting intravenous iron dose in hemodialysis: a proof of concept studySignal-intensity-ratio MRI accurately estimates hepatic iron load in hemodialysis patients.Renal artery stenosis evaluation in chronic kidney disease patients: nonenhanced time-spatial labeling inversion-pulse three-dimensional MR angiography with regulated breathing versus DSA.Further identification of human plasma glycoproteins interacting with the galactose-specific lectin Jacalin.Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution.[Peritoneal dialysis for acute renal failure: Rediscovery of an old modality of renal replacement therapy].Idiopathic membranous nephropathy: new therapeutic trends.Schoenlein-Henoch purpura with necrotizing vasculitis after cocaine snorting.[Short-term single-needle hemodialysis on native fistulae: a general review].[Anomalies of coagulation and thromboembolic complications of nephrotic syndromes]Iatrogenic iron overload and its potential consequences in patients on hemodialysis.[Drug treatments for uterine fibroma: rationale].Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency.[Smoking cessation in case of chronic kidney disease].Hepatic Iron Load at Magnetic Resonance Imaging Is Normal in Most Patients Receiving Peritoneal Dialysis.Candesartan cilexetil on regular hemodialysis: inability to reduce excessive thirst, but good tolerance and efficacy in hypertensive patients.Monoclonal immunoglobulins in patients with renal transplants: characterization, evolution and risk factors.Left-ventricular diastolic dysfunction as a risk factor for dialytic hypotension.[Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice].Re: Further Evidence Supporting the Accuracy of Quantitative Magnetic Resonance Imaging for Evaluating Iron Load in Dialysis Patients.The changing landscape of iron overload disorders at the beginning of the 21st century.A modified Cockcroft-Gault formula taking into account the body surface area gives a more accurate estimation of the glomerular filtration rate.[Significance of IGA antigliadin antibodies during primary glomerulonephritis with mesangial IGA deposits]Food allergy and idiopathic nephrotic syndrome.Cyclosporin in idiopathic steroid-resistant membranous glomerulonephritis.HFE gene mutations are not risk factors for iron overload in European hemodialysis patients.Parvovirus B19 and Schönlein-Henoch Purpura in AdultsWhen should iron supplementation in dialysis patients be avoided, minimized or withdrawn?[Cutaneous plasmacytoma]Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritisMucosal immunity in primary glomerulonephritis: II. Study of the serum IgA subclass repertoire to food and airborne antigens[Occupational chronic mercury poisoning. Two cases]Asymptomatic renal-vein thrombosis in adult nephrotic syndrome ultrasonography and urinary fibrin-fibrinogen products: a prospective study[Immune deficiency associated with experimental graft-versus-host reaction. Lack of correlation with T-cell cytotoxic activity]
P50
Q26752664-DBB10104-1D66-4F49-B5C3-E0F4235F3B0DQ34052385-14C3B607-0B11-49AC-BBC4-F700CC5EDADFQ34299291-E2CBD9A9-6A00-4A9A-9E4F-633FF74DDF88Q34704499-C1BFB0C7-A1A8-47FF-9C8A-E9160E378A8EQ34964011-8C6313A2-05CA-41DE-92CA-725C562BED1DQ35693595-9670D852-BF7A-409C-810D-11BAC5A790F3Q36315311-53CBF1AE-F299-4D42-8543-1FD938FF4005Q37570855-268EFF1C-C6DC-4EF3-9342-498AF74FAB17Q37844354-3F1C195E-64C2-48AA-B526-72C09D101E28Q38294374-9ABD2B08-FD9A-44A4-9353-9023FFBC4F3DQ38884441-5B50FB34-3F98-4DBE-AD2F-A5B91847D436Q40693415-8F771838-C3C5-4031-AB06-21C3F865F5C5Q40789111-9D41513C-08E9-43C7-B9C1-FE1700E68FECQ42566467-F3338D0D-E2A1-49EB-9980-7266489DF7C2Q42962204-965E45E0-8B2D-4661-B6B7-DEB3CB9DC957Q44592112-723D6C6D-58C6-4B3F-A413-2158BC9D2BAFQ46392404-F5D833A3-E786-4ABC-A0DF-DC844490A7D4Q46682133-DB6396ED-D827-4FDF-B89F-F6AD88ECD729Q46710776-3D3FFDDA-0C80-4E35-802B-BD58F98C1869Q46929858-6947761F-98EA-400A-8FBA-C0B31974F2DCQ47102467-40BCD69D-77F7-42B4-8AF7-4C072892759DQ48443824-8258DD65-A324-4A97-AEB8-66059A5ED8B2Q48551472-1261F133-050F-48E8-B0B0-9062CE907E51Q48574466-8331032A-F738-43DE-9DA9-6FA24A5D4F65Q48722800-59BDDC6B-F912-40E9-8347-14A927471332Q49393627-995FBB37-B344-4B2E-BD24-F9644E802330Q49709428-CA8DA45F-86D5-4F57-8C5A-C005C12C3533Q51904506-FE970A03-1E69-45CF-9F44-1C0B983F924AQ53995952-C0E17543-1A43-4E10-BE17-79D74CC3F8D0Q54342541-C75D61A1-F48D-47C1-B2B0-82ECAE275828Q54342660-C30231C8-314C-43B9-92AC-0F426877C13CQ54480672-D39BAF56-7062-4025-96EA-76EDC2D94633Q58325040-D4D5051D-6456-412A-A393-801118A0C6C4Q59357930-64AFE731-93FE-4ED8-8722-61316F14F684Q67246472-B35F4476-C194-4301-851B-4BEAA236C0B6Q67574234-EBBD9C52-089A-4DEC-8D94-60244871BCD8Q67816555-9A456889-D205-4170-92D1-B02A9F2A72FDQ67824771-520798FE-6FFF-4761-AB76-21287E8CCC8EQ67875266-19BC9899-3447-463D-BDCF-BC83901206B6Q67905677-F014476A-D7A9-4CDE-A0B9-A24C6046AC89
P50
description
researcher ORCID ID = 0000-0002-4383-3825
@en
wetenschapper
@nl
name
Guy Rostoker
@ast
Guy Rostoker
@en
Guy Rostoker
@es
Guy Rostoker
@nl
type
label
Guy Rostoker
@ast
Guy Rostoker
@en
Guy Rostoker
@es
Guy Rostoker
@nl
prefLabel
Guy Rostoker
@ast
Guy Rostoker
@en
Guy Rostoker
@es
Guy Rostoker
@nl
P31
P496
0000-0002-4383-3825